butylscopolammonium bromide has been researched along with tamarixetin in 1 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (tamarixetin) | Trials (tamarixetin) | Recent Studies (post-2010) (tamarixetin) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 58 | 7 | 42 |
| Protein | Taxonomy | butylscopolammonium bromide (IC50) | tamarixetin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.12 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 1.215 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.02 | |
| Aurora kinase B | Homo sapiens (human) | 7.39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
1 other study(ies) available for butylscopolammonium bromide and tamarixetin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |